Joint Pain Clinical Trial
Official title:
Evaluation of the Effect of Laser Acupuncture on Myalgia and Arthralgia During Docetaxel or Paclitaxel Treatment in Cancer Patients
This is a prospectively randomized and double-blinded clinical study. Cancer patients were suffered from the taxanes-induced joint pain, and would be advised to receive laser acupuncture in specific points to relieve pain. Clinical effects of analgesic changes would be evaluated before and after the intervention. The inflammation associated indices would be further analyzed to reveal the therapeutic mechanism of laser acupuncture. The laser acupuncture was expected to relief taxanes-induced adverse effects in patients and also can improve patients' life quality.
The current clinical study is prospectively randomized and double-blinded, and practice in Chang Gung Memorial Hospital in Linkou, TaoYuan and Taipei branches. All 90 participants suffered from taxanes-induced myalgia and Arthralgia, and will be randomly assigned into the experimental groups (45 participants) and the control group (45 participants). The experiment group would arrange laser acupuncture on day1 and day3 after Taxanes treatment, besides the control group arrange pseudo-laser acupuncture. In the mean while, blood tests were performed with the C-Reactive protein, erythrocyte sedimentation rate, Interleukin-6 for each participants. Evaluation would be records on day1, day3, and day 8 after Taxanes treatment. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05052112 -
Cross-Over Study to Evaluate the Efficacy of E-PR-01 on Activity Induced Joint Pain
|
N/A | |
| Recruiting |
NCT04285112 -
SPRINT: Signature for Pain Recovery IN Teens
|
||
| Completed |
NCT04506411 -
Turmeric Efficacy for Mobility and Joint Function
|
N/A | |
| Terminated |
NCT00973141 -
A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain
|
Phase 2 | |
| Completed |
NCT04408560 -
Evaluation of the Efficacy of a Homeopathic Protocol in Patients With Non-metastatic Breast Cancer
|
N/A | |
| Completed |
NCT04150211 -
Effects of Exten(d) Supplementation on Training Ability in Recreational Runners
|
Phase 2 | |
| Completed |
NCT03209895 -
Study to Evaluate the Safety and Efficacy of a Proprietary "Joint Health" Dietary Supplement in Subjects With Joint and Connective Tissue Pain
|
N/A | |
| Withdrawn |
NCT01612728 -
Treatment for Joint Pains Due to Aromatase Inhibitor Therapy in Breast Cancer
|
Phase 2 | |
| Completed |
NCT00691678 -
Glucosamine and Chondroitin for Aromatase Inhibitor Induced Joint Symptoms in Women With Breast Cancer
|
Phase 2 | |
| Recruiting |
NCT05212259 -
Clinical Study to Evaluate the Effect of Different Doses of UC-II® Supplementation on the Range of Motion & Joint Discomfort in Healthy Subjects
|
N/A | |
| Recruiting |
NCT04182659 -
Long Term Efficacy of Neuronavigation Guided rTMS in Alleviating Gulf War Illness Related Headaches and Pain Symptoms
|
N/A | |
| Terminated |
NCT04712019 -
Evaluating Edema and Range of Motion Using Negative Pressure Therapy vs. Standard Surgical Dressing in Bilateral TKA
|
N/A | |
| Recruiting |
NCT06074744 -
Subsartorial Nerve Block and Femoral Nerve Block in Total Knee Arthroplasty
|
N/A | |
| Recruiting |
NCT00325845 -
Synvisc Injections for Lumbar Facet Joint Pain
|
Phase 3 | |
| Active, not recruiting |
NCT03865992 -
Curcumin in Reducing Joint Pain in Breast Cancer Survivors With Aromatase Inhibitor-Induced Joint Disease
|
N/A | |
| Recruiting |
NCT05282992 -
NAtive Collagen Type II In Healthy VoluntEers With Joint Discomfort
|
N/A | |
| Recruiting |
NCT04994249 -
Diagnostic and Prognostic Biomarkers for High-impact Chronic Pain: Development and Validation
|
||
| Completed |
NCT01509079 -
Vitamin D3 Effects on Musculoskeletal Symptoms With Use of Aromatase Inhibitors
|
Phase 2 | |
| Completed |
NCT04764110 -
Short-term Impact of Cyplexinol® on Self-reported Joint Pain
|
N/A | |
| Not yet recruiting |
NCT06444867 -
A Study to Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of LEO 158968
|
Phase 1 |